Follow
Marie-Elyse Lafaille-Magnan
Marie-Elyse Lafaille-Magnan
Verified email at mail.mcgill.ca
Title
Cited by
Cited by
Year
Odor identification as a biomarker of preclinical AD in older adults at risk
ME Lafaille-Magnan, J Poirier, P Etienne, J Tremblay-Mercier, J Frenette, ...
Neurology 89 (4), 327-335, 2017
1072017
INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease
PF Meyer, J Tremblay-Mercier, J Leoutsakos, C Madjar, ...
Neurology 92 (18), e2070-e2080, 2019
1042019
Subjective cognitive decline is associated with altered default mode network connectivity in individuals with a family history of Alzheimer’s disease
SCJ Verfaillie, AP Binette, E Vachon-Presseau, S Tabrizi, M Savard, ...
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 3 (5), 463-472, 2018
512018
Test-retest resting-state fMRI in healthy elderly persons with a family history of Alzheimer’s disease
P Orban, C Madjar, M Savard, C Dansereau, A Tam, S Das, AC Evans, ...
Scientific data 2 (1), 1-11, 2015
342015
Amyloid and tau pathology associations with personality traits, neuropsychiatric symptoms, and cognitive lifestyle in the preclinical phases of sporadic and autosomal dominant …
AP Binette, É Vachon-Presseau, J Morris, R Bateman, T Benzinger, ...
Biological psychiatry 89 (8), 776-785, 2021
302021
Association of TLR4 with Alzheimer's disease risk and presymptomatic biomarkers of inflammation
J Miron, C Picard, MÉ Lafaille-Magnan, M Savard, A Labonté, J Breitner, ...
Alzheimer's & Dementia 15 (7), 951-960, 2019
242019
Open science datasets from PREVENT-AD, a longitudinal cohort of pre-symptomatic Alzheimer’s disease
J Tremblay-Mercier, C Madjar, S Das, AP Binette, SOM Dyke, P Étienne, ...
NeuroImage: Clinical 31, 102733, 2021
222021
APOE4 status is related to differences in memory-related brain function in asymptomatic older adults with family history of Alzheimer’s disease: Baseline analysis of the …
S Rabipour, S Rajagopal, E Yu, S Pasvanis, ME Lafaille-Magnan, ...
Journal of Alzheimer's Disease 76 (1), 97-119, 2020
102020
Association of elevated amyloid and tau positron emission tomography signal with near-term development of Alzheimer disease symptoms in older adults without cognitive impairment
C Strikwerda-Brown, DA Hobbs, J Gonneaud, F St-Onge, AP Binette, ...
JAMA neurology 79 (10), 975-985, 2022
92022
Odor identification as a biomarker for progression of pre-symptomatic Alzheimer's disease
ME Lafaille-Magnan
McGill University (Canada), 2018
22018
O1‐12‐05: Olfactory identification correlates with cerebral blood flow in cognitively normal adults at risk of Alzheimer's dementia
ME Lafaille-Magnan, C Madjar, R Hoge, JCS Breitner, ...
Alzheimer's & Dementia 11 (7S_Part_3), P160-P161, 2015
22015
P1‐585: CROSSTALK BETWEEN ENGLISH AND FRENCH FORMS OF THE RBANS IN AN ALZHEIMER'S DISEASE PREVENTION TRIAL
ME Lafaille-Magnan, JMS Leoutsakos, D Fontaine, C Madjar, J Kat, ...
Alzheimer's & Dementia 14 (7S_Part_10), P559-P560, 2018
12018
P4‐119: Olfactory identification is associated with verbal intrusion and primacy effects in cognitively normal adults at risk of Alzheimer's dementia
ME Lafaille-Magnan, D Fontaine, JCS Breitner, ...
Alzheimer's & Dementia 11 (7S_Part_18), P823-P824, 2015
12015
O2‐08‐06: PONDER: A cognitive training and prevention program—design, methodology, and first results
T Beaudry, ME Lafaille-Magnan, JC Pruessner
Alzheimer's & Dementia 11 (7S_Part_4), P193-P194, 2015
12015
IC‐P‐149: ASSOCIATION OF OLFACTORY PERFORMANCE AND HIPPOCAMPAL VOLUME IN PERSONS AT RISK OF ALZHEIMER'S DEMENTIA
ME Lafaille‐Magnan, L Collins, V Fonov, D Fontaine, P Etienne, J Poirier, ...
Alzheimer's & Dementia 10, P85-P86, 2014
12014
P1–160: Olfactory identification as a potential marker of presymptomatic Alzheimer's disease
ME Lafaille‐Magnan, J Breitner, P Etienne, J Poirier, D Fontaine, ...
Alzheimer's & Dementia 9, P208-P208, 2013
12013
Spatial Extent of Amyloid-β Levels and Associations With Tau-PET and Cognition
H Ozlen, AP Binette, T Köbe, PF Meyer, J Gonneaud, F St-Onge, ...
JAMA neurology 79 (10), 1025-1035, 2022
2022
Odor identification as a useful marker of presymptomatic AD
ME Lafaille-Magnan, JCS Breitner
2022
THE OLFACT TEST BATTERY (OTB) PREDICTS ALZHEIMER’S DISEASE
RSW Lloyd Hastings, Marie-Elyse Lafaille-Magnan, Steven Howe
Clinical Trials on Alzheimer's Disease 6 (The Journal of Prevention of …, 2019
2019
" INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease": Correction.
PF Meyer, J Tremblay-Mercier, J Leoutsakos, C Madjar, ...
Lippincott Williams & Wilkins, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–20